LC/MS is effective for the high sensitivity analysis of drugs; however, when protein is present and enters the MS (Mass Detector), it contaminates the MS or suppresses ionization of the sample. Pretreatment does not often remove protein thoroughly. Drugs in biological fluid are hard to analyze because protein co-elutes with the component of interest. The target drug receives ion suppression from the protein and appears as a small peak. ODP2 HP can separate the target from protein by eluting protein early and clearly. Barbital was introduced into the MS by a switching valve after BSA (protein) was eluted, and barbital was detected without any influence of ion suppression.
Sample : Barbital (500 ng/mL) in BSA (7.0 mg/L), 10 μL
Sample : Barbital (500 ng/mL) in BSA (7.0 mg/L), 10 μL
Column : Shodex ODP2 HP-2B (2.0 mm I.D. x 50 mm) Eluent : 10 mM Ammonium acetate aq./CH3CN=70/30 Flow rate : 0.2 mL/min Detector : UV (280 nm), ESI-MS (SIM negative) Column temp. : 30 °C
Sample Name Index
Operation Manual / Certificate of Analysis
Operation Manuals and Certificate of Analysis / Inspection Certificate for the following products can be downloaded here.
Product Name Index
Applications
- Indomethacin in Serum (ODP-50 6E)
- Procainamide in Serum (ODP-50 4D)
- LC/MS Analysis of Barbital in BSA (ODP2 HP-2B)
- LC/MS Analysis of Drugs in BSA (1) (ODP2 HP)
- LC/MS Analysis of Drugs in BSA (2) (ODP2 HP)
- LC/MS/MS Analysis of Tricyclic Antidepressants in BSA (ODP2 HP)
- LC/MS Analysis of Drugs in Control Serum (ODP2 HP)
- Reproducibility in LC/MS Analysis (ODP2 HP)
- Direct Analysis of Acetaminophen in Serum (ODP2 HP)
- Direct Analysis of Risperidone in Urine (ODP2 HP)
- Simultaneous Analysis of Multi Symptom Cold Formula in Serum (ODP2 HP)
- Analysis of Anticonvulsant in Serum (ODP2 HP)
- Hippuric Acid etc. in Urine (2)